这是一篇来自已证抗体库的有关
人类 DLL1的综述,是根据9篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合DLL1 抗体。
DLL1 同义词: DELTA1; DL1; Delta; NEDBAS
安迪生物R&D
小鼠 单克隆(251127) | | 安迪生物R&D DLL1抗体(R&D, FAB1818A)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1b). Stem Cell Reports (2021) ncbi |
BioLegend
小鼠 单克隆(MHD1-314) | | BioLegend DLL1抗体(BioLegend, MHD 1-314)被用于被用于流式细胞仪在人类样本上 (图 3). Cytotherapy (2015) ncbi |
小鼠 单克隆(MHD1-314) | | BioLegend DLL1抗体(Biolegend, MHD1-314)被用于被用于流式细胞仪在人类样本上 (表 1). Nat Immunol (2014) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(G-1) | - 流式细胞仪; 人类; 1:1000; 图 2a
- 免疫印迹; 人类; 1:1000; 图 s3a
| 圣克鲁斯生物技术 DLL1抗体(Santa, sc-377310)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (图 2a) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 s3a). Nat Commun (2018) ncbi |
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆 | | 艾博抗(上海)贸易有限公司 DLL1抗体(Abcam, ab10554)被用于被用于免疫细胞化学在人类样本上 (图 1). PLoS ONE (2016) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 DLL1抗体(Cell Signaling, 2588)被用于被用于免疫印迹在人类样本上 (图 s1b). Mol Cancer (2019) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 DLL1抗体(Cell Signaling Technology, 2588)被用于被用于免疫印迹在人类样本上 (图 3e). Cancer Res (2017) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 DLL1抗体(Cell Signaling, 2588)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:1000. Proc Natl Acad Sci U S A (2016) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 DLL1抗体(Cell Signaling, 2588)被用于被用于免疫印迹在人类样本上 (图 6d). Biochem Pharmacol (2016) ncbi |
Pretemer Y, Kawai S, Nagata S, Nishio M, Watanabe M, Tamaki S,
et al. Differentiation of Hypertrophic Chondrocytes from Human iPSCs for the In Vitro Modeling of Chondrodysplasias. Stem Cell Reports. 2021;16:610-625
pubmed 出版商
Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R,
et al. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019;18:156
pubmed 出版商
Mangolini M, Götte F, Moore A, Ammon T, Oelsner M, Lutzny Geier G,
et al. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia. Nat Commun. 2018;9:3839
pubmed 出版商
Jin L, Vu T, Yuan G, Datta P. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway. Cancer Res. 2017;77:5464-5478
pubmed 出版商
Kuzmanov U, Guo H, Buchsbaum D, Cosme J, Abbasi C, Isserlin R,
et al. Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy. Proc Natl Acad Sci U S A. 2016;113:12592-12597
pubmed
Greene M, Lai Y, Pajcini K, Bailis W, Pear W, Lancaster E. Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand. PLoS ONE. 2016;11:e0161157
pubmed 出版商
Zhang P, He D, Chen Z, Pan Q, Du F, Zang X,
et al. Chemotherapy enhances tumor vascularization via Notch signaling-mediated formation of tumor-derived endothelium in breast cancer. Biochem Pharmacol. 2016;118:18-30
pubmed 出版商
Kim H, Huang L, Critser P, Yang Z, Chan R, Wang L,
et al. Notch ligand Delta-like 1 promotes in vivo vasculogenesis in human cord blood-derived endothelial colony forming cells. Cytotherapy. 2015;17:579-92
pubmed 出版商
Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L,
et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364
pubmed 出版商